Literature DB >> 22613902

The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort.

Laura E Targownik1, Harminder Singh, Zoann Nugent, Charles N Bernstein.   

Abstract

OBJECTIVES: Previous studies have reported colectomy rates of over 50% in ulcerative colitis (UC), although changes in management may have influenced the rates of colectomy in the modern era. We sought to determine the incidence of colectomy in UC and identify risk factors associated with early colectomy (EC) and late colectomy (LC).
METHODS: We used the University of Manitoba Inflammatory Bowel Disease Epidemiology Database, a population-based data set including UC patients with up to 25 years of post diagnosis follow-up. We tracked the occurrence of total colectomy in all patients with known UC, subdivided into EC (≤90 days from diagnosis date) and LC (>90 days from diagnosis). Survival curves were created and stratified by age, sex, era of diagnosis, and inpatient/hospital diagnosis. Cox proportional hazards modeling was used to determine which risk factors were predictive of either EC or LC.
RESULTS: Among 3,752 patients with UC, 367 underwent colectomy. The 5-, 10- and 20-year actuarial risk of requiring colectomy was 7.5%, 10.4%, and 14.8%, respectively. Male sex (hazard ratio (HR): 2.63, [corrected] 95% confidence interval (CI): 1.58-4.36) and being initially diagnosed during a hospitalization (HR: 12.46, 95% CI: 7.40-21.0) were predictive of EC after adjustment for confounders. In-hospital diagnosis was predictive of LC, whereas being diagnosed more recently was protective against LC (HR: 0.96, 95% CI: 0.93-0.98).
CONCLUSIONS: The cumulative incidence of colectomy in UC is lower than previously reported, and appears to be decreasing further among more recently diagnosed cohorts of patients. Male sex and hospitalization at the time of diagnosis are major risk factors for EC and LC.

Entities:  

Mesh:

Year:  2012        PMID: 22613902     DOI: 10.1038/ajg.2012.127

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  79 in total

Review 1.  The Role of Early Biologic Therapy in Inflammatory Bowel Disease.

Authors:  Dana Rachel Berg; Jean-Frederic Colombel; Ryan Ungaro
Journal:  Inflamm Bowel Dis       Date:  2019-11-14       Impact factor: 5.325

2.  Anxiety, depression, and inflammation after restorative proctocolectomy.

Authors:  Venkata Subhash Gorrepati; Sanjay Yadav; August Stuart; Walter Koltun; Evangelos Messaris; Emmanuelle D Williams; Matthew D Coates
Journal:  Int J Colorectal Dis       Date:  2018-06-29       Impact factor: 2.571

Review 3.  Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies.

Authors:  Peter Stepaniuk; Charles N Bernstein; Laura E Targownik; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

Review 4.  Laparoscopic surgery for ulcerative colitis: a review of the literature.

Authors:  Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Kazushige Kawai; Tomomichi Kiyomatsu; Junichiro Tanaka; Toshiaki Tanaka; Takeshi Nishikawa; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-10-28       Impact factor: 2.549

5.  Gut reaction.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2018-11       Impact factor: 49.962

6.  Incidence Rates and Predictors of Colectomy for Ulcerative Colitis in the Era of Biologics: Results from a Provincial Database.

Authors:  Maria Abou Khalil; Marylise Boutros; Hacene Nedjar; Nancy Morin; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Philip Gordon; Elham Rahme
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

Review 7.  The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care.

Authors:  Jonathan A Beard; Diana L Franco; Benjamin H Click
Journal:  Curr Gastroenterol Rep       Date:  2020-01-30

Review 8.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

9.  Elective surgery outcomes in inflammatory bowel disease: interpretation at magnetic resonance enterography.

Authors:  Giuseppe Cicero; Giorgio Ascenti; Alfredo Blandino; Renato Trimarchi; Christian Booz; Thomas J Vogl; Tommaso D'Angelo; Silvio Mazziotti
Journal:  Jpn J Radiol       Date:  2021-02-24       Impact factor: 2.374

10.  Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease.

Authors:  A N Ananthakrishnan; E L McGinley
Journal:  Aliment Pharmacol Ther       Date:  2013-03-04       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.